CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -32.5% | 15,186 | 0.0% | 0.00% | – |
| Q1 2022 | $40,000 | -25.9% | 15,186 | +83.1% | 0.00% | – |
| Q4 2020 | $54,000 | +575.0% | 8,292 | +761.1% | 0.00% | – |
| Q2 2020 | $8,000 | -97.9% | 963 | -98.1% | 0.00% | -100.0% |
| Q1 2020 | $380,000 | -7.8% | 49,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $412,000 | +9.3% | 49,600 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $377,000 | -34.3% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | +4.4% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $550,000 | -6.9% | 51,200 | +30.6% | 0.00% | 0.0% |
| Q4 2018 | $591,000 | -18.5% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $725,000 | – | 39,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |